Study Stopped
Sponsor decision
A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer
1 other identifier
observational
N/A
1 country
1
Brief Summary
This study seeks to correlate microbial sequencing data from a punch biopsy in patients with skin cancer both melanoma and non-melanoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2019
CompletedFirst Posted
Study publicly available on registry
September 23, 2019
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedJune 5, 2025
April 1, 2021
1 year
September 18, 2019
June 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation of Skin Microbiome to Cancer via Relative Abundance Found in Microbiome Sequencing
Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the skin microbiome in both cancerous and non-cancerous areas. These data will then be compared to elucidate unique qualities of the microbiome in skin cancer.
1 year
Secondary Outcomes (1)
Validation of sequencing methods
1 year
Interventions
There is no intervention for this study
Eligibility Criteria
Adults 18 and older with a diagnosis of skin cancer
You may qualify if:
- Signed informed consent
- years of age or older
- Diagnosis of skin cancer, both melanoma and non-melanoma
- Able/willing to have a skin punch biopsy in a non-cancerous location
You may not qualify if:
- Unable/unwilling to sign informed consent
- Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ProgenaBiomelead
Study Sites (1)
ProgenaBiome
Ventura, California, 93003, United States
Biospecimen
Punch biopsies of skin from both cancerous and non-cancerous areas.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabine Hazan, MD
ProgenaBiome
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2019
First Posted
September 23, 2019
Study Start
October 1, 2019
Primary Completion
October 1, 2020
Study Completion
December 1, 2020
Last Updated
June 5, 2025
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share
Only aggregated, deidentified data will be made available to other researchers.